Literature DB >> 29567726

Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement.

Jakko van Ingen1, Timothy Aksamit2, Claire Andrejak3,4, Erik C Böttger5, Emmanuelle Cambau6, Charles L Daley7, David E Griffith8, Lorenzo Guglielmetti9,10, Steven M Holland11, Gwen A Huitt7, Won-Jung Koh12, Christoph Lange13,14,15,16, Philip Leitman17, Theodore K Marras18, Kozo Morimoto19, Kenneth N Olivier20, Miguel Santin21, Jason E Stout22, Rachel Thomson23,24, Enrico Tortoli25, Richard J Wallace26, Kevin L Winthrop27, Dirk Wagner28.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29567726      PMCID: PMC6660914          DOI: 10.1183/13993003.00170-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  47 in total

1.  Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research.

Authors:  Shelby Daniel-Wayman; Getahun Abate; Daniel L Barber; Luiz E Bermudez; Rhea N Coler; Michael H Cynamon; Charles L Daley; Rebecca M Davidson; Thomas Dick; R Andres Floto; Emily Henkle; Steven M Holland; Mary Jackson; Richard E Lee; Eric L Nuermberger; Kenneth N Olivier; Diane J Ordway; D Rebecca Prevots; James C Sacchettini; Max Salfinger; Christopher M Sassetti; Christine F Sizemore; Kevin L Winthrop; Adrian M Zelazny
Journal:  Am J Respir Crit Care Med       Date:  2019-04-15       Impact factor: 21.405

2.  Treatment Outcomes of Cavitary Nodular Bronchiectatic-Type Mycobacterium avium Complex Pulmonary Disease.

Authors:  Ganghee Chae; Yea Eun Park; Yong Pil Chong; Hyun Joo Lee; Tae Sun Shim; Kyung-Wook Jo
Journal:  Antimicrob Agents Chemother       Date:  2022-08-11       Impact factor: 5.938

3.  Isolation and Characterization of vB_MsmS_Celfi: A New Mycobacterium tuberculosis Bacteriophage.

Authors:  Florencia Payaslian; Victoria Gradaschi; Liliana Rondón Salazar; Maria Eugenia Dieterle; Estefanía Urdániz; Matias Di Paola; José Peña Cárcamo; Fabio Zon; Ezequiel Sosa; Darío Fernandez Do Porto; Matthew Dunne; Pauline Goeller; Jochen Klumpp; Raúl Ricardo Raya; Alejandro Reyes; Mariana Piuri
Journal:  Phage (New Rochelle)       Date:  2021-03-17

4.  Potential Cross-Transmission of Mycobacterium abscessus among Non-Cystic Fibrosis Patients at a Tertiary Hospital in Japan.

Authors:  Keiji Fujiwara; Mitsunori Yoshida; Yoshiro Murase; Akio Aono; Koji Furuuchi; Yoshiaki Tanaka; Ken Ohta; Manabu Ato; Satoshi Mitarai; Kozo Morimoto
Journal:  Microbiol Spectr       Date:  2022-05-10

5.  In Vitro MIC Values of Rifampin and Ethambutol and Treatment Outcome in Mycobacterium avium Complex Lung Disease.

Authors:  Yong Pil Chong; Kyung-Wook Jo; Byoung Soo Kwon; Mi-Na Kim; Heungsup Sung; Younsuck Koh; Woo-Sung Kim; Jin-Woo Song; Yeon-Mok Oh; Sang-Do Lee; Sei Won Lee; Jae-Seung Lee; Chae-Man Lim; Chang-Min Choi; Jin-Won Huh; Sang-Bum Hong; Sojung Park; Tae Sun Shim
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

Review 6.  NTM drug discovery: status, gaps and the way forward.

Authors:  Mu-Lu Wu; Dinah B Aziz; Véronique Dartois; Thomas Dick
Journal:  Drug Discov Today       Date:  2018-04-07       Impact factor: 7.851

7.  Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.

Authors:  Sun Hye Shin; Byung Woo Jhun; Su-Young Kim; Junsu Choe; Kyeongman Jeon; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Sung Jae Shin; Charles L Daley; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

8.  Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Eur Respir J       Date:  2020-07-07       Impact factor: 16.671

9.  Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

10.  Impact of Susceptibility to Injectable Antibiotics on the Treatment Outcomes of Mycobacterium abscessus Pulmonary Disease.

Authors:  Youngmok Park; Yea Eun Park; Byung Woo Jhun; Jimyung Park; Nakwon Kwak; Kyung-Wook Jo; Jae-Joon Yim; Tae Sun Shim; Young Ae Kang
Journal:  Open Forum Infect Dis       Date:  2021-05-12       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.